Compile Data Set for Download or QSAR
Report error Found 122 Enz. Inhib. hit(s) with Target = 'Transient receptor potential cation channel subfamily M member 5'
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571573(CHEMBL4863993)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571573(CHEMBL4863993)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571634(CHEMBL4877000)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
LigandPNGBDBM50571573(CHEMBL4863993)
Affinity DataEC50:  16nMAssay Description:Agonist activity at mouse TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571635(CHEMBL4856061)
Affinity DataEC50:  18nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571618(CHEMBL4869759)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571636(CHEMBL4855103)
Affinity DataEC50:  29nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571637(CHEMBL4857667)
Affinity DataEC50:  38nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571617(CHEMBL4860824)
Affinity DataEC50:  39nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
LigandPNGBDBM50571572(CHEMBL4854482)
Affinity DataEC50:  44nMAssay Description:Agonist activity at mouse TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571572(CHEMBL4854482)
Affinity DataEC50:  44nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602146(CHEMBL5177026)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602165(CHEMBL5193084)
Affinity DataEC50:  63nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
LigandPNGBDBM50571571(CHEMBL4849726)
Affinity DataEC50:  85nMAssay Description:Agonist activity at mouse TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571638(CHEMBL4845759)
Affinity DataEC50:  85nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571571(CHEMBL4849726)
Affinity DataEC50:  89nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571619(CHEMBL4873593)
Affinity DataEC50:  98nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602162(CHEMBL5194924)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571639(CHEMBL4862183)
Affinity DataEC50:  102nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  125nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  126nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571605(CHEMBL4869736)
Affinity DataEC50:  158nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571607(CHEMBL4863223)
Affinity DataEC50:  158nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602164(CHEMBL5186500)
Affinity DataEC50:  200nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602163(CHEMBL5189636)
Affinity DataEC50:  200nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  251nMAssay Description:Agonist activity at mouse TRPM5 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602170(CHEMBL5188072)
Affinity DataEC50:  251nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571640(CHEMBL4866122)
Affinity DataEC50:  295nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571641(CHEMBL4849376)
Affinity DataEC50:  309nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602160(CHEMBL5179994)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602148(CHEMBL5181952)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571570(CHEMBL4876211)
Affinity DataEC50:  331nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571606(CHEMBL4863555)
Affinity DataEC50:  447nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571592(CHEMBL4855887)
Affinity DataEC50:  457nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571611(CHEMBL4849797)
Affinity DataEC50:  468nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571620(CHEMBL4858854)
Affinity DataEC50:  468nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571598(CHEMBL4874619)
Affinity DataEC50:  490nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602159(CHEMBL5202815)
Affinity DataEC50:  501nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602147(CHEMBL5209164)
Affinity DataEC50:  501nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571599(CHEMBL4866780)
Affinity DataEC50:  575nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602136(CHEMBL5183139)
Affinity DataIC50: 600nMAssay Description:Antagonist activity at TRPM5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602137(CHEMBL5196998)
Affinity DataIC50: 600nMAssay Description:Antagonist activity at TRPM5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602135(CHEMBL5209032)
Affinity DataEC50:  631nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602141(CHEMBL5175850)
Affinity DataEC50:  794nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571616(CHEMBL4867011)
Affinity DataEC50:  832nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
LigandPNGBDBM50571570(CHEMBL4876211)
Affinity DataEC50:  891nMAssay Description:Agonist activity at mouse TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571623(CHEMBL4872165)
Affinity DataEC50:  933nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602161(CHEMBL5184410)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571624(CHEMBL4848175)
Affinity DataEC50:  1.18E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells maintained at 80 mV final holding potential by syncroPatch assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602149(CHEMBL5175871)
Affinity DataEC50:  1.26E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
Displayed 1 to 50 (of 122 total ) | Next | Last >>
Jump to: